Gerrit Jan Wolbink

20192019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2019 2019

  • 3 Article
  • 1 Comment/Letter to the editor

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39

Spiliopoulou, A., Colombo, M., Plant, D., Nair, N., Cui, J., Coenen, M. J. H., Ikari, K., Yamanaka, H., Saevarsdottir, S., Padyukov, L., Bridges, S. L., Kimberly, R. P., Okada, Y., van Riel, P. L. C. M., Wolbink, G., van der Horst-Bruinsma, I. E., de Vries, N., Tak, P. P., Ohmura, K., Canhão, H. & 12 othersGuchelaar, H-J., Huizinga, T. W. J., Criswell, L. A., Raychaudhuri, S., Weinblatt, M. E., Wilson, A. G., Mariette, X., Isaacs, J. D., Morgan, A. W., Pitzalis, C., Barton, A. & McKeigue, P., 2019, In : Annals of the Rheumatic Diseases.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay

Berkhout, L. C., l'Ami, M. J., Ruwaard, J., Hart, M. H., Ooijevaar-de Heer, P., Bloem, K., Nurmohamed, M. T., van Vollenhoven, R. F., Boers, M., Alvarez, D. F., Smith, C. H., Wolbink, G. J. & Rispens, T., 2019, In : Science Translational Medicine. 11, 477, aat3356.

Research output: Contribution to journalArticleAcademicpeer-review

Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis

l’ Ami, M. J., Ruwaard, J., Krieckaert, C. L. M., Nurmohamed, M. T., van Vollenhoven, R. F., Rispens, T. & Wolbink, G. J., 2019, In : Scandinavian Journal of Rheumatology.

Research output: Contribution to journalArticleAcademicpeer-review